In this study, the expression of well-established mesothelioma markers (Calretinin, Keratin 5/6, and WT1) in addition to new markers (D2-40 and Mesothelioma Ab1) [14–17] was investigated in 87 meningioma cases and compared to EMA expression. This evidence concerns the gene CALB2 and meningioma.